2. Asthma
ā¢ What is it?
ā¢ Pathogenesis and types + Drug targets in pathogenesis
ā¢ Clinical Manifestation
ā¢ Physical exam
ā¢ Diagnostic study,Ddx
ā¢ Management-GINA
ā¢ Exarcebations
3. TAKING HX
ā« Since when it start & previous attack?
Eg.since 4 years old, once in 2 months, last attack was on October
Day time Sx/week,nocturnal awakening/month,Use of SABA to releive
symptoms,intereference with normal activities between
exarcebations,exarcebation/year.
ā« Aggravating and relieving factors?
Eg.cold drinks, cold weather or do vigorous exercise
ā« Have any prolong URTI sx?
ā« Prev hospital administration?
Eg.No hospital administration before this.
ā« History of atopy? ā Eg.No eczema or has rhinitis etc
ā« Family history of asthma? -Eg.Strong family hx of asthma
5. ADVANCED LAB / IMMUNOLOGICAL TESTING
ā¢ For patients with severe persistent asthma, a CBC and differential (to evaluate
the presence/absence of eosinophils and exclude anemia as a cause of
dyspnea) and a total serum immunoglobulin E (IgE) level (eg, for allergic
bronchopulmonary aspergillosis [ABPA] or for identification of candidates for
anti-IgE therapy) are usually obtained.
ā¢ Specific testing for aspergillus sensitization (skin test or immunoassay) and an
antineutrophil cytoplasmic antibody (ANCA) are performed in those with high
blood eosinophils to evaluate for ABPA and eosinophilic granulomatosis with
polyangiitis (EGPA, Churg-Strauss), respectively
6. UPON DIAGNOSIS OF ASTHMA IN THE
ABOVE PATIENT, WHAT WOULD BE THE
FIRST CHOICE OF TREATMENT?
HOW TO DECIDE THE BEST INHALER?
āReleivers Vs Controllersā
7. Management principles
ā¢ Education and avoidance of environmental triggers
ā¢ Use quick-relief rescue medication as needed for all Pts
ā¢ Goal to achieve complete control = daily sx ā¤2/wk, ā nocturnal sx
or limitation of activity, reliever med ā¤2/wk, nl peak expiratory
flow rate or FEV1; partly controlled = 1ā2 of the above present in a
wk; uncontrolled = ā„3 of the above present in a wk
ā¢ Step up treatment as needed to gain control, step down as
tolerated
12. HOW CAN WE PREDICT FUTURE
RISK OF EXACERBATIONS?
13. WHY IS IT IMPORTANT TO PREVENT
EXACERBATIONS?
1. Cost to patient and healthcare system
2. To prevent Lung function decline
3. Improve quality of life
4. All of above